118 related articles for article (PubMed ID: 8822941)
1. Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells.
Chen CL; Fuscoe JC; Liu Q; Relling MV
Blood; 1996 Sep; 88(6):2210-8. PubMed ID: 8822941
[TBL] [Abstract][Full Text] [Related]
2. A human lymphoid leukemia cell line with a V(D)J recombinase-mediated deletion of hprt.
Chen CL; Woo MH; Neale GA; Goorha RM; Fuscoe JC; Behm FG; Mathew S; Relling MV
Mutat Res; 1998 Jul; 403(1-2):113-25. PubMed ID: 9726012
[TBL] [Abstract][Full Text] [Related]
3. Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide.
Chen CL; Fuscoe JC; Liu Q; Pui CH; Mahmoud HH; Relling MV
J Natl Cancer Inst; 1996 Dec; 88(24):1840-7. PubMed ID: 8961974
[TBL] [Abstract][Full Text] [Related]
4. Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans.
Fuscoe JC; Vira LK; Collard DD; Moore MM
Environ Mol Mutagen; 1997; 29(1):28-35. PubMed ID: 9020304
[TBL] [Abstract][Full Text] [Related]
5. The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy.
Fuscoe JC; Knapp GW; Hanley NM; Setzer RW; Sandlund JT; Pui CH; Relling MV
Mutat Res; 1998 Nov; 419(1-3):107-21. PubMed ID: 9804912
[TBL] [Abstract][Full Text] [Related]
6. Prevalent involvement of illegitimate V(D)J recombination in chromosome 9p21 deletions in lymphoid leukemia.
Kitagawa Y; Inoue K; Sasaki S; Hayashi Y; Matsuo Y; Lieber MR; Mizoguchi H; Yokota J; Kohno T
J Biol Chem; 2002 Nov; 277(48):46289-97. PubMed ID: 12228235
[TBL] [Abstract][Full Text] [Related]
7. Quantification of illegitimate V(D)J recombinase-mediated mutations in lymphocytes of newborns and adults.
Scheerer JB; Xi L; Knapp GW; Setzer RW; Bigbee WL; Fuscoe JC
Mutat Res; 1999 Dec; 431(2):291-303. PubMed ID: 10635995
[TBL] [Abstract][Full Text] [Related]
8. V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans.
Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Burnette L; Moore MM; Nicklas JA; O'Neill JP; Albertini RJ
Mutat Res; 1992 Sep; 283(1):13-20. PubMed ID: 1380658
[TBL] [Abstract][Full Text] [Related]
9. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
Finette BA; Poseno T; Albertini RJ
Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
[TBL] [Abstract][Full Text] [Related]
10. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes.
Fuscoe JC; Zimmerman LJ; Lippert MJ; Nicklas JA; O'Neill JP; Albertini RJ
Cancer Res; 1991 Nov; 51(21):6001-5. PubMed ID: 1933863
[TBL] [Abstract][Full Text] [Related]
11. V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.
Messier TL; O'Neill JP; Finette BA
Hum Mutat; 2006 Aug; 27(8):829. PubMed ID: 16835902
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
Raghavan SC; Kirsch IR; Lieber MR
J Biol Chem; 2001 Aug; 276(31):29126-33. PubMed ID: 11390401
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous Quantification of t(14;18) and HPRT Exon 2/3 Deletions in Human Lymphocytes.
Fuscoe JC
Methods Mol Biol; 2020; 2102():361-370. PubMed ID: 31989567
[TBL] [Abstract][Full Text] [Related]
14. Kinds and locations of mutations induced in the hypoxanthine-guanine phosphoribosyltransferase gene of human T-lymphocytes by 1-nitrosopyrene, including those caused by V(D)J recombinase.
McGregor WG; Maher VM; McCormick JJ
Cancer Res; 1994 Aug; 54(15):4207-13. PubMed ID: 8033153
[TBL] [Abstract][Full Text] [Related]
15. Formation of large deletions by illegitimate recombination in the HPRT gene of primary human fibroblasts.
Morris T; Thacker J
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1392-6. PubMed ID: 8433997
[TBL] [Abstract][Full Text] [Related]
16. The frequency of illegitimate TCRbeta/gamma gene recombination in human lymphocytes: influence of age, environmental exposure and cytostatic treatment, and correlation with frequencies of t(14;18) and hprt mutation.
Meydan D; Nilsson T; Törnblom M; Hagmar L; Hellgren D; Fuscoe JC; Lambert B
Mutat Res; 1999 Aug; 444(2):393-403. PubMed ID: 10521679
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous quantification of t(14;18) and HPRT exon 2/3 deletions in human lymphocytes.
Fuscoe JC
Methods Mol Biol; 2014; 1105():303-11. PubMed ID: 24623238
[TBL] [Abstract][Full Text] [Related]
18. Molecular description of three macro-deletions and an Alu-Alu recombination-mediated duplication in the HPRT gene in four patients with Lesch-Nyhan disease.
Brooks EM; Branda RF; Nicklas JA; O'Neill JP
Mutat Res; 2001 May; 476(1-2):43-54. PubMed ID: 11336982
[TBL] [Abstract][Full Text] [Related]
19. Fine mapping of V(D)J recombinase mediated rearrangements in human lymphoid malignancies.
Halper-Stromberg E; Steranka J; Giraldo-Castillo N; Fuller T; Desiderio S; Burns KH
BMC Genomics; 2013 Aug; 14():565. PubMed ID: 23957733
[TBL] [Abstract][Full Text] [Related]
20. Impact of maternal lifestyle factors on newborn HPRT mutant frequencies and molecular spectrum--initial results from the Prenatal Exposures and Preeclampsia Prevention (PEPP) Study.
Bigbee WL; Day RD; Grant SG; Keohavong P; Xi L; Zhang L; Ness RB
Mutat Res; 1999 Dec; 431(2):279-89. PubMed ID: 10635994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]